Company News-royal proclamation
 
Pearl Diver
Procedure of the Month tools

Take the Multiple Choice Test Which choice best describes the patient's treatment options?

xray-spinal fusion
Sponsored by...
US Spine
Steven G. Anderson, President, Founder & CEO / Source: RRY Publications

CryoLife’s Takeover Attempt Gets Weird
Robin Young • Tue, Feb 23rd, 2010
1 Comment

 

Medafor, the manufacturer of a powder hemostat, metaphorically dumped it on CEO Steven G. Anderson’s head with last week’s strong rejection of CryoLife’s hostile takeover bid. Fully 99% of Medafor’s shareholders have ignored CryoLife’s appeals. Read more.

Leonardo Da Vinci, Vitruvian Man

How Medical Technology Investing Really Works
Robin Young • Tue, Feb 9th, 2010
2 Comments

 

Recent high profile failures of medical technology start-up firms drives home some important lessons. Namely the key to successful medical technology investing is NOT in the technology it is in the cheap SOB running the company.

Image source: RRY Publications

Bruising Biologics Battle Erupts
Robin Young • Tue, Jan 26th, 2010

 

Last week, CryoLife slammed Medafor against the boards by mailing an open letter to Medafor’s shareholders urging them to override management’s decision NOT to sell to CryoLife. The gloves are off and CryoLife’s Steve Anderson is back in his customary Bad Boy role.

Photo source: RRY Publications

2010: Through a Glass Darkly
Robin Young • Tue, Dec 29th, 2009

 

If 2009 was the year of recovery, will 2010 be the year of decline? What should manufacturers, surgeons, and providers expect in the New Year? On balance, we think there is more cause for anxiety than optimism. But then, like most prognosticators, we’ve been wrong before. Check out our analysis here.

John Brown

The Picture of Success: John Brown
Elizabeth Hofheinz, M.P.H., M.Ed. • Tue, Dec 8th, 2009

 

John Brown, former head of Stryker, had heavy responsibilities from the time he could hold a garden hoe. From rural Tennessee to the “big city,” Brown became an icon, and led Stryker to consistent 20% earnings.

Fire Fighting / Wikimedia Commons

NuVasive Fights Back
Walter Eisner • Mon, Dec 7th, 2009

 

NuVasive fights back and says there are no coding or reimbursement issues for its XLIF procedure. But questions about future reimbursements and a slew of short sales have cut the company’s market cap by almost $600 million in the last two months. Read what company CEO Lukianov told analysts on November 30.

Tightrope Walking/Wikimedia Commons

Spine Market Shows Stability in 3Q
Matt Menze, PearlDiver Spine Analyst • Wed, Dec 2nd, 2009

 

The spine product market as a whole continues to see revenue growth at a steady rate. Smaller companies, however, face a capital crunch and possible acquisition. Which companies will come out on top? Read it here.